Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-30 @ 7:58 AM
Study NCT ID:
NCT01694758
Status:
COMPLETED
Last Update Posted:
2014-08-15
First Post:
2012-09-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-25
First Submit QC Date:
None
Study First Post Date:
2012-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-13
Last Update Post Date:
2014-08-15
Last Update Post Date Type:
ESTIMATED